Coco Gauff appears to support WTA efforts to protect sport’s fairness, laments ‘attack’ on trans community
American tennis star Coco Gauff has commented on the Women's Tennis Association's (WTA) new SRY gene-testing policy, which is designed to verify eligibility and protect fair competition in women's tennis by screening out male competitors. Gauff appeared to endorse the policy while simultaneously expressing sympathy for transgender people, describing what she called an "attack" on the trans community. Her remarks place her among prominent athletes navigating the contentious debate over transgender inclusion and fairness in women's sport.
The article, published by Fox News's OutKick, frames Gauff's comments within a wider ongoing controversy involving women's sports bodies, including the WNBA and WTA, over policies on transgender and intersex athletes. It references related discussions, such as scrutiny of a French transgender player in women's basketball and broader debate about eligibility testing, though it provides limited direct quotation or detail of what Gauff specifically said.
In short
- Coco Gauff addressed WTA's SRY gene-testing eligibility policy
- She appeared to support the policy while backing the trans community
- Comes amid wider sports debate on transgender athlete inclusion
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Advocates of the WTA policy argue that fair competition is foundational to women's sport, and that biological differences create measurable performance advantages which threaten the category's integrity and the opportunities female athletes have trained their lives to access. They contend that objective eligibility standards protect women's athletics and need not reflect hostility toward transgender people as human beings, but rather a commitment to preserving the meaning and accessibility of their sporting category.
The case against
Opponents argue that mandatory genetic testing is invasive and stigmatising, and that evidence for widespread competitive unfairness remains limited whilst such policies disproportionately burden transgender athletes. They contend that meaningful inclusion requires nuanced, individualised approaches rather than categorical exclusions, and that blanket eligibility testing treats trans athletes as inherently suspect in ways not applied to other competitors, raising concerns about whether fairness arguments are masking discriminatory intent.
Explained simply
The WTA is the body that runs the main professional tennis tour for women. It sets rules for who may compete in its events, including eligibility rules intended to ensure that players meet the criteria for the women’s category.
Transgender people have a gender identity different from the sex they were assigned at birth; intersex people are born with sex traits that do not fit typical definitions of male or female. Sports bodies have faced debate over how to set eligibility rules, balancing inclusion with their stated aim of fair competition.
SRY is a gene involved in typical male sex development, and some sports organisations have considered testing for it as part of eligibility checks. The issue matters because such rules can affect who is allowed to compete and raise questions about privacy, fairness and how athletes are treated.